Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,253

AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram

Surawicz, B., Childers, R., Deal, B. J., & Gettes, L. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.013 · Cited by 2,053

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975

Drug-induced prolongation of the QT interval

Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

Wang, Q. K., Shen, J., Splawski, I., Atkinson, D. L., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,682

Risk Stratification in the Long-QT Syndrome

Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,456

MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia

Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,353

Approaches to Sudden Death from Coronary Heart Disease

Lown, B., & Wolf, M. A. (1971) · Circulation · doi:10.1161/01.cir.44.1.130 · Cited by 1,258

Atypical antipsychotic drugs and the risk of sudden cardiac death

Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194

Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012

Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End‐Stage Kidney Disease

Assimon, M. M., Wang, L., Pun, P. H., Winkelmayer­, W. C., & Flythe, J. E. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.015969 · Cited by 15

The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants

Lopez-Medina, A. I., Chahal, C. A. A., & Luzum, J. A. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0027 · Cited by 18

Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure

Assimon, M. M., Pun, P. H., Wang, L. H.-C., Al‐Khatib, S. M., Brookhart, M. A., Weber, D. J., Winkelmayer­, W. C., & Flythe, J. E. (2022) · Kidney International · doi:10.1016/j.kint.2022.05.024 · Cited by 15

Computer-Assisted Interventions To Improve QTc Documentation in Patients Receiving QT-Prolonging Drugs

Sandau, K. E., Sendelbach, S. E., Fletcher, L., Frederickson, J., Drew, B. J., & Funk, M. (2015) · American Journal of Critical Care · doi:10.4037/ajcc2015240 · Cited by 15

Effect of Ondansetron on QT Interval in Patients Cared for in the PICU

Trivedi, S. S., Schiltz, B. M., Kanipakam, R., Bos, J. M., Ackerman, M. J., & Ouellette, Y. (2016) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000776 · Cited by 15

Electrophysiology Translational Considerations in Cardio-Oncology: QT and Beyond

Alomar, M., & Fradley, M. G. (2019) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-019-09924-y · Cited by 16

Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis

Johnson, T. M., Rivera, C. G., Lee, G., & Zeuli, J. D. (2024) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2024.100470 · Cited by 17

An Updated Safety Review of the Relationship Between Atypical Antipsychotic Drugs, the QTc Interval and Torsades de Pointe As: Implications for Clinical Use

Melo, L., Pillai, A. A., Kompella, R., Patail, H., & Aronow, W. S. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2392002 · Cited by 16

Flavonoids and hERG channels: Friends or foes?

Saponara, S., Fusi, F., Iovinelli, D., Ahmed, A., Trezza, A., Spiga, O., Sgaragli, G., & Valoti, M. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174030 · Cited by 14

Antidepressant or Antipsychotic Overdose in the Intensive Care Unit – Identification of Patients at Risk

Borg, L., Julkunen‐Iivari, A., Madsen, K. R., Strøm, T., & Toft, P. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12541 · Cited by 14

Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls

Lazzerini, P. E., Capecchi, P. L., & Pasini, F. L. (2016) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000189 · Cited by 14

The clinical significance of QT prolongation associated with tamoxifen: A review of the literature

Fung, K., Imeson, J., & Cusano, F. L. (2017) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155217720006 · Cited by 14

A literature-based algorithm for the assessment, management, and monitoring of drug-induced QTc prolongation in the psychiatric population

Zolezzi, M., & Cheung, L. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s186474 · Cited by 15

Inpatient cardiac monitoring using a patch‐based mobile cardiac telemetry system during the COVID‐19 pandemic

Braunstein, E. D., Reynbakh, O., KRUMERMAN, A. K., Biase, L. D., & Ferrick, K. J. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14727 · Cited by 14

QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients

Minguito‐Carazo, C., Echarte‐Morales, J., Benito‐González, T., Castillo-García, S. D., Rodríguez-Santamarta, M., Sánchez-Muñoz, E., Maniega, C. G., García, R. B., Menéndez-Suárez, P., Gonzalez, S., et al. (2021) · Global Heart · doi:10.5334/gh.916 · Cited by 14

PONV management in patients with QTc prolongation on the EKG

Soghomonyan, S., Stoicea, N., Ackermann, W., & Bhandary, S. P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565704 · Cited by 14

Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors

Andric, T., Winckel, K., Tanzer, T. D., Hollingworth, S., Smith, L., Isoardi, K., Tan, O., & Siskind, D. J. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221104947 · Cited by 14

Manejo de los pacientes con fibrilación auricular en los servicios de urgencias hospitalarios (actualización 2012)

Martı́n, A., Lozano, I. F., Puig, B. C.-V., Tercedor, L., del Arco, C., Ynsaurriaga, F. A., Méndez, C. S., & Girbau, L. M. (2012) · Emergencias · Cited by 14

The link between ventricular repolarization variables and arterial function

Mozos, I. M. (2014) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2014.11.008 · Cited by 14

Cost–benefit and cost–savings analyses of antiarrhythmic medication monitoring

Snider, M. J., Carnes, C. A., Grover, J., Davis, R., & Kalbfleisch, S. J. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110270 · Cited by 14

Atomoxetine-induced life-threatening long QT syndrome

Štuhec, M., & Švab, V. (2013) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-013-0925-y · Cited by 14

Effect of Dexmedetomidine on Heart Rate-Corrected QT and Tpeak–Tend Intervals During Robot-Assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position

Kim, N. Y., Han, D. W., Koh, J. C., Rha, K. H., Hong, J. H., Park, J. M., & Kim, S. Y. (2016) · Medicine · doi:10.1097/md.0000000000003645 · Cited by 14

Emerging Implications of Genetic Testing in Inherited Primary Arrhythmia Syndromes

Asatryan, B., & Medeiros-Domingo, A. (2019) · Cardiology in Review · doi:10.1097/crd.0000000000000203 · Cited by 11

Comparison of clinical presentation and incidence of cardiopulmonary complications between male and female Thai patients with early systemic sclerosis: inception cohort study

Wangkaew, S., Tungteerabunditkul, S., Prasertwittayakij, N., & Euathrongchit, J. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04551-z · Cited by 14

QTc prolongation among hydroxychloroquine sulphate‐treated COVID‐19 patients: An observational study

Fteiha, B., Karameh, H., Kurd, R., Ziff‐Werman, B., Feldman, I., Bnaya, A., Einav, S., Orlev, A., & Ben‐Chetrit, E. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13767 · Cited by 13

No QTc prolongation in girls and women with Turner syndrome

Noordman, I. D., Duijnhouwer, A. L., Coert, M., Bos, M., Kempers, M., Timmers, H. J. L. M., Fejzic, Z., van der Velden, J. A. E. M., & Kapusta, L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa552 · Cited by 13

Quantitative T-wave alternans analysis for guiding medical therapy: An underexploited opportunity

Verrier, R. L., & Malík, M. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.10.006 · Cited by 13

Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis

Putnikovic, M., Jordan, Z., Munn, Z., Borg, C., & Ward, M. (2022) · Drug Safety · doi:10.1007/s40264-022-01215-x · Cited by 13

High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study

Yuan, N., Oesterle, A., Botting, P. G., Chugh, S. S., Albert, C. M., Ebinger, J. E., & Ouyang, D. (2023) · JMIR Cardio · doi:10.2196/41055 · Cited by 13

Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies

Graciaa, D., Schechter, M., Fetalvero, K., Cranmer, L., Kempker, R., & Castro, K. (2023) · Expert Review of Anti-Infective Therapy · doi:10.1080/14787210.2023.2207820 · Cited by 9

Impact of preoperative QTc interval prolongation on short-term postoperative outcomes: A retrospective study

Ho, C., Chung, W.-C., Kao, C., Hsu, C., Hung, K.-C., Yu, C., Chen, J., & Chen, I. (2024) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2024.111574 · Cited by 13

QT correction across the heart rate spectrum, in atrial fibrillation and ventricular conduction defects

Vandenberk, B., Vandael, E., Robyns, T., Vandenberghe, J. U., Garweg, C., Foulon, V., Ector, J., & Willems, R. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13423 · Cited by 14

The risk of cardiac events in patients who received concomitant levofloxacin and amiodarone

Brunetti, L., Lee, S.-M., Nahass, R., Suh, D., Miao, B., Bucek, J. L., Kim, D.-W., Kim, O.-K., & Suh, D. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.10.017 · Cited by 13

QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia

Barreto, J. N., Cullen, M. W., Mara, K. C., Grove, M. E., Sierzchulski, A. G., Dahl, N. J., Tosh, P. K., Dierkhising, R., Patnaik, M. M., & Ackerman, M. J. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1639165 · Cited by 13

Transient Hypogonadism Is Associated With Heart Rate–Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men

Lazzerini, P. E., Cantara, S., Bertolozzi, I., Accioli, R., Salvini, V., Cartocci, A., D’Errico, A., Sestini, F., Bisogno, S., Cevenini, G., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.023371 · Cited by 13

Management of Arrhythmias in the Perioperative Setting

Melduni, R. M., Koshino, Y., & Shen, W.-K. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.08.006 · Cited by 13

A Wavelet-Based Algorithm for Delineation and Classification of Wave Patterns in Continuous Holter ECG Recordings.

Johannesen, L., Grove, U., Sørensen, J., Schmidt, M., Couderc, J., & Graff, C. (2010) · PubMed · Cited by 13

Pro-Arrhythmic Effects of Noncardiac Medications

Viskin, S., Havakuk, O., & Schwaber, M. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.027 · Cited by 13

Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk

Lazzerini, P. E., Bertolozzi, I., Rossi, M., Capecchi, P. L., & Pasini, F. L. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.090 · Cited by 13

QT interval dynamics in patients with ST-elevation MI

Mann, T. D., Moses, A., Yesaulov, A., Hochstadt, A., Granot, Y. N., Rosso, R., Shacham, Y., & Chorin, E. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1056456 · Cited by 12

A real-world pharmacovigilance study of QT interval prolongation and Torsades de Pointes associated with CDK4/6 inhibitors in breast cancer patients: findings from the FDA adverse event reporting system

Yu, Y., Wu, B., & Wang, L. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2307375 · Cited by 12

Antipsychotic-Induced QT Prolongation and Torsade de Pointes in Patients with Mental Disorders: A Review

Nasyrova, R. F., Kidyaeva, A. V., Петрова, М. М., & Shnayder, N. A. (2024) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2024-410 · Cited by 12

The Effect of a Combination Treatment Using Palonosetron, Promethazine, and Dexamethasone on the Prophylaxis of Postoperative Nausea and Vomiting and QTc Interval Duration in Patients Undergoing Craniotomy under General Anesthesia: A Pilot Study

Bergese, S. D., Puente-Poushnejad, E., Antor, M. A., Capo, G., Yildiz, V. O., & Uribe, A. A. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00001 · Cited by 12

Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19

Echarte‐Morales, J., Minguito‐Carazo, C., Castillo-García, S. D., Borrego-Rodríguez, J., Rodríguez-Santamarta, M., Sánchez-Muñoz, E., García, R. B., Maniega, C. G., Gonzalez, S., Menéndez-Suárez, P., et al. (2020) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2020.11.012 · Cited by 12

Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients

Das, B., Ramasubbu, S. K., Kumar, B., & Rawat, V. S. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1060_20 · Cited by 15

Vomiting, electrolyte disturbance, and medications; the perfect storm for acquired long QT syndrome and cardiac arrest: a case report

Tiver, K. D., Dharmaprani, D., Quah, J. X., Lahiri, A., Waddell-Smith, K. E., & Ganesan, A. N. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-021-03204-7 · Cited by 12

C-reactive Protein Elevation Is Associated With QTc Interval Prolongation in Patients Hospitalized With COVID-19

Isakadze, N., Engels, M. C., Beer, D. A., McClellan, R., Yanek, L. R., Mondaloo, B., Hays, A. G., Metkus, T. S., Calkins, H. G., & Barth, A. S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.866146 · Cited by 12

Methadone Therapy in Underserved Urban Community: QT c Prolongation and Life‐Threatening Ventricular Arrhythmias

Chowdhury, M., Wong, J., Cheng, A., Khilkin, M., & Palma, E. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12120 · Cited by 12

Prevalence and Prognostic Significance of Long QT Interval in Patients With Acute Coronary Syndrome

Hasanien, A. A., Drew, B. J., & Howie‐Esquivel, J. (2013) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31829bcf1a · Cited by 12

Overdrive pacing in a patient with incessant torsades de pointes

Overbey, A. N., Austin, A. L., Seidensticker, D. F., & Lin, A. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-200146 · Cited by 12

Propofol-associated QTc prolongation

Scalese, M. J., Herring, H. R., Rathbun, R. C., Skrepnek, G. H., & Ripley, T. L. (2016) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098616641354 · Cited by 12

Cases of drug-induced Torsade de Pointes: a review of Belgian cases in the EudraVigilance database

Vandael, E., Vandenberk, B., Vandenberghe, J. U., Willems, R., & Foulon, V. (2017) · Acta Clinica Belgica · doi:10.1080/17843286.2017.1300217 · Cited by 12

Prevalence and prognostic significance of prolonged QTc interval in emergency medical patients: A prospective observational study

Kumar, S., Birda, C. L., Bhalla, A., Sharma, N., & Kumari, S. (2018) · International Journal of Critical Illness and Injury Science · doi:10.4103/ijciis.ijciis_59_17 · Cited by 12

Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data

Hincapie‐Castillo, J. M., Staley, B. J., Henriksen, C. H., Saidi, A. S., Lipori, G. P., & Winterstein, A. G. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz100 · Cited by 14

Elevating performance and interpretability of in silico classifiers for drug proarrhythmia risk evaluations using multi-biomarker approach with ranking algorithm

Qauli, A. I., Nurul Qashri Mahardika, T., Hanum, U. L., Vanheusden, F. J., & Lim, K. M. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.108609 · Cited by 11

Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies

Cuni, R., Parrini, I., Asteggiano, R., & Conte, M. R. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-016-0460-5 · Cited by 12

Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort Study

Fung, K. W., Baye, F. M., Kapusnik-Uner, J., & McDonald, C. J. (2021) · Drugs - Real World Outcomes · doi:10.1007/s40801-021-00230-1 · Cited by 14

Characteristics of Presentations to the Emergency Department Following Attempted Suicide with Drugs

Kummer, M., Müller, T., Exadaktylos, A. K., Krähenbühl, S., & Liakoni, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910232 · Cited by 11

A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics

He, L., Yu, Y., Zhang, L., He, S., Yu, W., Li, L., Huang, J., & Li, H. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001501 · Cited by 11

A randomized, single‐dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophrenia

Tsukada, H., Milanovic, S. M., Darpö, B., Xue, H., Xiong, K., Tripp, E., Lennek, L., Worden, M., Hopkins, S. C., & Galluppi, G. R. (2023) · Clinical and Translational Science · doi:10.1111/cts.13512 · Cited by 10

Grupo de Trabajo Conjunto sobre cirugía no cardiaca: Evaluación y manejo cardiovascular de la Sociedad Europea de Cardiología (ESC) y la European Society of Anesthesiology (ESA)

Kristensen, S. D., Knuuti, J. M., Saraste, A., Anker, S. D., Bøtker, H. E., Hert, S. G. D., Ford, I., González‐Juanatey, J. R., Görenek, B., Heyndrickx, G. R., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.11.001 · Cited by 13

Agreement Between ICU Clinicians and Electrophysiology Cardiologists on the Decision to Initiate a QT c‐interval Prolonging Medication in Critically Ill Patients with Potential Risk Factors for Torsade de Pointes: A Comparative, Case‐Based Evaluation

Fongemie, J., Al‐Qadheeb, N. S., Estes, N. A. M., Roberts, R. J., Temtanakitpaisan, Y., Ruthazer, R., & Devlin, J. W. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1242 · Cited by 11

Prevalence of Torsades de Pointes inducing drugs usage among elderly outpatients in North Jordan Hospitals

Al‐Azayzih, A., Gharaibeh, S., Jarab, A. S., & Mukattash, T. L. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.07.002 · Cited by 11

Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation

Naksuk, N., Sugrue, A. M., Padmanabhan, D., Kella, D., DeSimone, C. V., Kapa, S., Asirvatham, S. J., Lee, H.-C., Ackerman, M. J., & Noseworthy, P. A. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0476-2 · Cited by 11

The use of a clinical decision support tool to assess the risk of QT drug–drug interactions in community pharmacies

Berger, F. A., van der Sijs, H., van Gelder, T., & van den Bemt, P. M. L. A. (2021) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098621996098 · Cited by 11

Assessing Prescriber Behavior with a Clinical Decision Support Tool to Prevent Drug-Induced Long QT Syndrome

Trinkley, K. E., Pell, J. M., Martinez, D. D., Maude, N. R., Hale, G., & Rosenberg, M. A. (2021) · Applied Clinical Informatics · doi:10.1055/s-0041-1724043 · Cited by 11

Percentile categorization of QT interval as an approach for identifying adult patients at risk for cardiovascular death

Mohebi, R., Jehan, A. S., Grober, A. F., & Froelicher, V. F. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.002 · Cited by 11

Correction to: Evaluation of Index of Cardio-Electrophysiological Balance in Patients With Atrial Fibrillation on Antiarrhythmic-Drug Therapy

Afşin, A., Asoğlu, R., Kobat, M. A., Asoğlu, E., & Süner, A. (2021) · Cardiology Research · doi:10.14740/cr1185c1 · Cited by 11

Perioperative arrhythmias

Pecha, S., Kirchhof, P. F., & Reißmann, B. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2023.0052 · Cited by 10

Elevated Interleukin‐6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans

Lazzerini, P. E., Cupelli, M., Cartocci, A., Bertolozzi, I., Salvini, V., Accioli, R., Salvadori, F., Marzotti, T., Verrengia, D., Cevenini, G., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032071 · Cited by 10

Adverse clinical events caused by pacemaker battery depletion: two case reports

Liu, J., Li, W., Yao, S., Zheng, P., Zhao, S., & Yang, J. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01622-x · Cited by 10

Drug-induced long qt syndrome

Golovina, G., Zaphiraki, K. V., & Kosmacheva, E. D. (2020) · Journal of Arrhythmology · doi:10.35336/va-2020-3-42-52 · Cited by 10

Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic review

Skullbacka, S., Airaksinen, M., Puustinen, J., & Toivo, T. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03285-3 · Cited by 10

Action potential metrics and automated data analysis pipeline for cardiotoxicity testing using optically mapped hiPSC-derived 3D cardiac microtissues

Soepriatna, A. H., Navarrete-Welton, A., Kim, T. Y., Daley, M. C., Bronk, P., Kofron, C. M., Mende, U., Coulombe, K. L. K., & Choi, B. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280406 · Cited by 10

Predictors of Polymorphic Ventricular Tachycardia and Ventricular Fibrillation in Patients With Takotsubo Syndrome

Chedid, M., BUDA, K. G., Iqbal, O., & Simegn, M. A. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.04.053 · Cited by 10

Long QT syndrome, cardiovascular anomaly and findings in ECG-guided genetic testing

Al-Senaidi, K. S., Wang, G., Zhang, L., Beer, D. A., Farqani, A. M. A., Al-Maskaryi, S. N., Penny, D. J., Kowey, P. R., & Fan, Y. (2014) · IJC Heart & Vessels · doi:10.1016/j.ijchv.2014.06.001 · Cited by 10

The QT Scale: A Weight Scale Measuring the QTc Interval

Couderc, J., Besaw, C., Niu, X., Serrano‐Finetti, E., Casas, Ó., Pallas-Areny, R., Rosero, S. Z., & Zaręba, W. (2016) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12378 · Cited by 10

Reduced functional connectivity between ventromedial prefrontal cortex and insula relates to longer corrected QT interval in HIV+ and HIV− individuals

McIntosh, R. C., Chow, D. C., Lum, C. J., Hidalgo, M., Shikuma, C. M., & Kallianpur, K. J. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.07.398 · Cited by 10

Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring

Simoons, M., Seldenrijk, A., Mulder, H., Birkenhäger, T. K., Groothedde-Kuyvenhoven, M. M., Kok, R., Kramers, C., Verbeeck, W., Westra, M., van Roon, E., et al. (2018) · Drug Safety · doi:10.1007/s40264-018-0649-z · Cited by 10

Significance of prolonged QTc in acute exacerbations of COPD requiring hospitalization

Oekelen, O. V., Vermeersch, K., Everaerts, S., Vandenberk, B., Willems, R., & Janssens, W. (2018) · International Journal of COPD · doi:10.2147/copd.s157630 · Cited by 10

Arzneimittelinteraktionen, die man kennen muss!

Voigt, N., Ort, K. R., & Sossalla, S. T. (2019) · Pneumologie · doi:10.1055/a-0863-6242 · Cited by 10

Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic

Carron, J., Sharif, Z. I., Hussein, H., Kennedy, M., McAdam, B. F., & Sheahan, R. G. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02291-7 · Cited by 10

QT interval measurement in ventricular pacing: Implications for assessment of drug effects and pro-arrhythmia risk

Schurr, J. W., Grewal, P. K., Fan, R., & Rashba, E. J. (2021) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2021.11.029 · Cited by 10

Implementation of a fully remote randomized clinical trial with cardiac monitoring

Mayfield, J. J., Chatterjee, N. A., Noseworthy, P. A., Poole, J. E., Ackerman, M. J., Stewart, J. C., KISSINGER, P. J., Dwyer, J., Hosek, S., Oyedele, T., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00052-w · Cited by 10

First, Do No Harm: QT Interval Screening in Methadone Maintenance Treatment

Haigney, M. C. (2011) · Journal of Addictive Diseases · doi:10.1080/10550887.2011.610704 · Cited by 10

Management of prolonged QT interval and torsades de pointes in the intoxicated patient.

Kan, A. A., de Lange, D. W., Donker, D. W., & Meulenbelt, J. (2014) · PubMed · Cited by 10

Duloxetine-induced life-threatening long QT syndrome

Štuhec, M. (2013) · Wiener klinische Wochenschrift · doi:10.1007/s00508-013-0330-6 · Cited by 10

Basic Cardiac Electrophysiology and Common Drug-induced Arrhythmias

Lee, A., & Pickham, D. M. (2016) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2016.04.007 · Cited by 10

Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting

Marill, K. A., & Miller, E. S. (2017) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2017.02.001 · Cited by 10

QTc prolongation during antiviral therapy in two COVID‐19 patients

Zhu, S., Wang, J., Wang, Y., Chu, J., Liu, Y. Z., Chen, X., & Chen, X. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13183 · Cited by 10

Role of Pharmacokinetics and Pharmacogenetics of Antidepressant-Induced Prolongation of the QT Interval and Torsade de Pointes in Patients with Mental Disorders

Shnayder, N. A., Kidyaeva, A. V., Vaiman, E. E., Asadullin, A. R., Петрова, М. М., Kaskaeva, D. S., Matyushin, G. V., Evsyukov, A. A., Galko, E. V., Garganeeva, N. P., et al. (2023) · Personalized Psychiatry and Neurology · doi:10.52667/2712-9179-2023-3-2-72-119 · Cited by 11

Obesity Arrhythmias: Role of IL-6 Trans-Signaling

Aromolaran, K. A., Corbin, A. C., & Aromolaran, A. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158407 · Cited by 9

Real-World Data on Osimertinib-Associated Cardiac Toxicity

Agbarya, A., Raphael, A., Sorotsky, H. G., Rottenberg, Y., Šebek, V., Radonjic, D., Yakobson, A., Arnon, J., & Shalata, W. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051754 · Cited by 9

Impact of the FDA Warning for Azithromycin and Risk for QT Prolongation on Utilization at an Academic Medical Center

Dunker, A., Kolanczyk, D. M., Maendel, C. M., Patel, A. R., & Pettit, N. N. (2016) · Hospital Pharmacy · doi:10.1310/hpj5110-830 · Cited by 9

Osborn Wave Is Related to Ventricular Fibrillation and Tachycardia in Hypothermic Patients

Okada, N., Matsuyama, T., Morita, S., Ehara, N., Miyamae, N., Okada, Y., Jo, T., Sumida, Y., Watanabe, M., Nozawa, M., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-19-0856 · Cited by 9

Ventricular Arrhythmia Risk Based on Ethnicity in COVID-19 Patients on Hydroxychloroquine and Azithromycin Combination: Viewpoint

Roy, S., & MainakMukhopadhyay (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00370-5 · Cited by 8

Added value of patient‐ and drug‐related factors to stratify drug‐drug interaction alerts for risk of QT prolongation: Development and validation of a risk prediction model

Muylle, K. M., Laere, S. V., Pannone, L., Coenen, S., de Asmundis, C., Dupont, A. G., & Cornu, P. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15580 · Cited by 9

Protected from Torsades de Pointes? What Psychiatrists Need to Know About Pacemakers and Defibrillators

Brojmohun, A., Lou, J., Zardkoohi, O., & Funk, M. C. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.02.011 · Cited by 9

Disritmias cardíacas e anestesia

Lorentz, M. N., & Vianna, B. S. B. (2011) · Brazilian Journal of Anesthesiology · doi:10.1590/s0034-70942011000600013 · Cited by 9

Drug interactions and creatinine levels are associated with QTc prolongation in intensive care units: a prospective, observational study

Hosseinpoor, Z., Farzanegan, B., Seyyedi, S. R., Rajabi, M., & Baniasadi, S. (2019) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2019-0022 · Cited by 9

Prevention of Torsade de Pointes in Hospital Settings A Scientific Statement From the American Heart Association and the

Menon, V., Roden, D. M., Zareba, W., Drew, B. J., Ackerman, M. J., Funk, M., & Gibler, W. B. (2010)

2010 AHA/ACCF Scientific Statement for Prevention of Torsade de Pointes in Hospital Settings

Chong-bai, X. (2011) · Advances in Cardiovascular Diseases

Incidence of Torsade de Pointes in a teriary hospital population

Vandael, E., Vandenberk, B., Vandenberghe, J. U., Pincé, H., Willems, R., & Foulon, V. (2016) · Acta Cardiologica

[Torsades de pointes].

Kishi, F., Nomura, M., Saito, K., Ito, S., & Nakaya, Y. (1996) · PubMed

Torsade de pointes.

Santinelli, V., Chiariello, M., & Condorelli, M. (1982) · Circulation · doi:10.1161/01.cir.66.1.250 · Cited by 6